Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Momo (MOMO) Tops Q2 EPS by 8c; offers guidance
• Bessent at Charlotte Private Luncheon warns China AI win would 'negate all else', targets 80% compute share by 2028
• Hewlett Packard Enterprise (HPE) Tops Q3 EPS by 19c; raises guidance